| Literature DB >> 16237987 |
Eugenio Stabile1, Edouard Cheneau, Timothy Kinnaird, William O Suddath, Neil J Weissman, Rebecca Torguson, Kenneth M Kent, Augusto D Pichard, Lowell F Satler, Ron Waksman.
Abstract
Drug-eluting stents, since their approval in the United States, have become the treatment of choice for de novo coronary artery narrowing due to their ability to reduce restenosis and the need for repeat revascularization. We present two patients who underwent percutaneous coronary intervention for the treatment of multivessel coronary artery disease; both patients were treated with sirolimus-eluting stents (SES) and bare metal stents (BMS).Entities:
Mesh：
Substances：
Year: 2004 PMID： 16237987 DOI： 10.1016/j.carrad.2004.11.001
Source DB: PubMed Journal: Cardiovasc Radiat Med ISSN： 1522-1865